Genetype - Unlocking personalised preventative health Genetic Technologies (ASX: GTG, NASDAQ Global Market: GENE) is a leader in the development and commercialisation of genetic risk assessment technology. Significant progress has been made in understanding the role of hereditary risk in chronic disease, however, many chronic conditions cannot be predicted by this risk alone. We’re transforming the conversation. Transitioning from a one-size-fits-all model to personalised, predictive health assessment – where each person has the information, they need to manage their health according to their own risk. Backed by over 20 years of experience, our doctors, scientist and technicians are translating genetic information into multi-tests that uniquely combine genetic and clinical risk models to predict risk of chronic diseases before onset. We’re empowering physicians to improve health outcomes for people around the world. Tracking disease to its source. Enabling a new era of personalised medicine.
| Website | https://genetype.com/ |
| Employees | 22 (5 on RocketReach) |
| Founded | 1989 |
| Phone | +1 704-926-5700 |
| Industry | Biotechnology Research |
| Keywords | Genetic Risk Assessment, Dna Testing, Genetic Testing, Health Diagnostics, Personalized Medicine, Predictive Health, Genetic Screening, Genomics, Precision Medicine, Healthcare Technology, Biotechnology, Genetic Analysis, Disease Prediction, Health Analytics, Dna Sequencing, Medical Technology, Genetic Research, Pharmacogenomics, Molecular Diagnostics |
| Competitors | Ancestry, MyHeritage, Helix, Gene by Gene, FamilyTreeDNA, Living DNA, Genomelink, DNAfit, Nutrigenomix®, 23andMe Inc +12 more (view full list) |
Looking for a particular GeneType employee's phone or email?
5 people are employed at GeneType.